SHIFT (Completed) Systolic Heart failure treatment with the If inhibitor ivabradine Trial Medicine ivabradine Population Heart failure Phase III Starting year 2006 Publicaties SHIFT Director of Study dr. T. Lenderink (Cardioloog) Heerlen, Zuyderland Medisch Centrum
